NCT03820778View on ClinicalTrials.gov

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2022

Conditions
Neurofibromatosis 1NeurofibromaAtypical NeurofibromaAtypical NeurofibromatosisPlexiform NeurofibromaVon Recklinghausen Disease
Interventions
DIAGNOSTIC_TEST

Whole Body MRI

WBMRI with axial and coronal STIR (short inversion time inversion recovery) images + DWI (diffuse weighted imaging) will be performed and compared to regional MRI to assess value of this diagnostic test for the identification of suspicious looking lesions (i.e. diffuse nodular lesions or atypical plexiform neurofibroma)

Trial Locations (1)

20010

Children's National Health System, Washington D.C.

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER